Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial

Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial

Abstract Background Perioperative chemotherapy combined with D2 radical gastrectomy has been proven to be the standard treatment for local advanced gastric cancer. However, tumor regression grading (TRG) is the only neoadjuvant chemotherapy (NACT) response evaluation criterion recommended by the NCC...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuejun Gan, Yongning Jia, Fei Shan, Xiangji Ying, Shuangxi Li, Yan Zhang, Fei Pang, Ziyu Li
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Cancer
Subjects:
Gastric cancer
Neoadjuvant chemotherapy (NACT)
Tumor regression grading (TRG)
Tumor marker (TM)
Response evaluation
Online Access:https://doi.org/10.1186/s12885-024-13372-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13372-6

Similar Items